16 August 2018
Visiongain’s new report Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China indicates that the pharma wholesale and distribution market will see $1,195bn in spending in 2021.
The pharma wholesale and distribution market is estimated at $893.69bn in 2016 and is expected to grow at a CAGR of 6.0% in the first half of the forecast period. The market is expected to grow at a CAGR of 5.2% from 2017-2027. In 2016, the branded drugs submarket held 79.5% share of the pharma wholesale and distribution market.
The lead analyst of this report said “The pharmaceutical wholesale and distribution market will be driven by an overall increased demand for pharmaceuticals. This is a result of the growing ageing population in developed countries and the increasing access to healthcare of the expanding middle class in the emerging economies.
Market expansion will be partially offset by reduced revenue generation of branded products as patents expire and cheaper generic version become available. Additionally, specialty products will continue to generate revenue, even after their patent protection is lost owing to the complexity of copying these products.”
The 265-page report contains 83 tables and 97 figures that add visual analysis in order to explain the developing trends within the pharma wholesale and distribution market.
Visiongain provides revenue forecasts for the period 2017-2027 as well as qualitative analyses for the pharma wholesale and distribution market and its leading submarkets: Branded Drugs, Generic Drugs, Other Medicines.
The 265-page report offers market forecasts for the leading national markets: US, Germany, France, The UK, Italy, Spain, Japan, China, Brazil, Russia and India
Moreover, our work discusses the leading companies in the pharma wholesale and distribution market. Our study also includes SWOT and STEP analysis of this industry and market.
The report Pharma Wholesale and Distribution Market Forecasts 2017-2027: Branded and Generic Drug Distribution, Leading National Markets, Leading Wholesalers, US, Europe, Japan and China report will be of value to anyone who wants to better understand the pharma wholesale and distribution market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the pharma wholesale and distribution market.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business conferences, newsletters, management reports and e-zines focusing on the automotive, chemical, cyber, defence, energy, pharmaceutical, materials and telecoms sectors.
Visiongain publishes reports produced by its analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.
10 September 2019
The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.
09 September 2019
Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.
05 September 2019
Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.